Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouMost face cream samples get approved in a climate-controlled room at 22 °C and 50% relative humidity — conditions that exist almost nowhere in the Gulf during summer. A cream that reads as “light”…
Most face cream samples get approved in a climate-controlled room at 22 °C and 50% relative humidity — conditions that exist almost nowhere in the Gulf during summer. A cream that reads as “light” and “fast-absorbing” in a Shanghai or Guangzhou lab can feel like a film, a sheen, or a sticky layer after twenty minutes on skin in Dubai, Jeddah, or Doha. If your sample approval process does not include a humidity-conditioned after-feel score, you are not approving a product for the Gulf market; you are approving a product for your testing room. This guide sets out how buyers should structure sample evaluation for non-greasy face creams, which attributes to score, which evidence to request from the manufacturer, and where the real red lines sit between “lighter” and “compromised.”
After-feel is not one sensation. It is the sum of several physical behaviours on skin, and each behaves differently under heat and humidity. Before you score anything, agree on what the market will actually judge:
“Non-greasy” is not a spec. Break it into attributes that a panel can score and an instrument can check, and write an acceptance gate for each before the first sample arrives:
The gates below are illustrative starting points, not universal thresholds — set yours against your positioning, price tier, and comparator. What matters is that each row has a defined method and a document that proves the result.
| Attribute | How to measure | When | Example pass gate | Evidence to request |
|---|---|---|---|---|
| Oiliness / shine | Panel score 0–10 plus standardized photography under fixed lighting | 15 min, 4 h, 8 h | Mean ≤ 3.0 and at least 1 point better than comparator at 4 h | Score table with per-subject data, image set, panel protocol |
| Tack / stickiness | Panel score 0–10 with defined touch protocol (press-and-release on cheek) | 15 min, 4 h | Mean ≤ 2.5; no subject above 5 | Questionnaire wording and full frequency distribution |
| Absorption speed | Time to non-transfer on blotting film, measured by technician | 0–15 min | ≤ 5 minutes median | Timed test record |
| Residue transfer | Standardized blot test, gravimetric or image-graded | 30 min, 4 h | Transfer grade ≤ low on 80% of subjects | Blot images, grading rubric |
| Sebum control | Sebumeter readings plus consumer diary | Baseline, 4 h, 8 h; diary over 2–4 weeks | Statistically significant improvement vs comparator at the stated timepoint | Instrumental raw data, diary analysis, statistical report |
| Pilling / layering | Application of cream + sunscreen + makeup, panel-graded | 10 min after full layering | Pilling score ≤ 2 on 0–10 in ≥ 85% of subjects | Layering protocol and compatibility note |
| Hydration feel | Corneometer plus “comfort / not tight” panel item | 2 h, 8 h | Hydration increase vs baseline with no increase in tack score | Instrumental + panel correlation table |
| Fragrance intensity | Panel score and stability check on colour and odour | 15 min, 4 h; 40 °C storage checkpoints | Within declared intensity band; no odour drift at 3 months | Fragrance brief, IFRA conformity statement, allergen declaration |
Score every sample round in both a standard room (approximately 22 °C / 50% RH) and a stress condition representative of the target market (for example 30–35 °C / 70–80% RH). The delta between the two is the most useful number you will get: it tells you how much the formula drifts when humidity rises. A sample that scores 2/10 in the standard room and 5/10 under stress is a different commercial risk from one that scores 3/10 in both.
Fix the dose (for example 0.5 g per application or a defined mg/cm²), the application site, the cleansing routine before application, and the acclimatization time in the test room. If the pack is a pump, record the delivered dose per actuation and confirm it matches the dose used in testing. Without this, panel scores are not comparable between rounds or between suppliers.
For directional screening, a small internal panel is acceptable. For any number you intend to publish or put on a label, plan the consumer study properly: a defined target-consumer population, blind-coded samples, randomized and balanced application order, and a sample size agreed with your regulatory reviewer before recruitment. A claim built on 20 colleagues is not a claim; it is an anecdote with a percentage sign.
A statement such as “90% agree the cream feels non-greasy after 8 hours” is a consumer-perception claim, and it only holds if every element of the test is fixed and documented:
Two further guards matter in the Gulf context. First, avoid turning an instrumental result into a perception claim or the reverse — sebumeter data supports a “reduces shine” style claim, while a HUT result supports an “agree it feels” style claim, and the two are not interchangeable. Second, keep SPF out of the after-feel conversation unless the product is genuinely a sunscreen; SPF products follow a separate regulatory pathway and cannot be approved on a cosmetic sample dossier.
Format is not a cosmetic afterthought in this category — it directly controls dose and therefore perception. A cream that scores well from a controlled lab syringe can fail from a jar because consumers scoop three times the tested dose.
Whatever the format, lock compatibility before you approve the sample:
| Phase | What happens | Typical duration | Evidence produced |
|---|---|---|---|
| Brief and formula selection | Agree after-feel targets, comparator, pack direction, and claim intent | 1–2 weeks | Signed brief with scoring gates |
| Lab sample round | Two to three prototype textures against the brief | 2–3 weeks | Spec sheets, sample log |
| Internal sensory screening | Standard-room and stress-condition panel scoring | 3–5 days | Scorecard per prototype |
| Stability and compatibility start | Accelerated and cycling stability, pack compatibility launched in parallel | Runs in background, 8–12 weeks to a usable dataset | Interim and final stability reports |
| Consumer HUT | Field study in the target market or a matched climate | 3–5 weeks including recruitment and reporting | HUT report with questionnaire and N |
| Packaging lock and pilot | Decoration, filling trial, dose verification | 3–6 weeks after artwork approval | Pilot batch record, dose-per-actuation check |
| Documentation handoff | Full dossier assembled and reviewed | 1–2 weeks | Complete evidence pack |
Fastest safe path (roughly 10–12 weeks): use an existing base formula and a catalogue pack, run one stress condition instead of two, and start stability on day one of the first prototype. What you may compress: the number of prototype rounds and the internal screening panel size. What you may not compress: stability duration, preservative efficacy, or the consumer study design for any claim you intend to publish.
Standard path (roughly 16–20 weeks): two prototype rounds, both test environments, full cycling stability, a properly powered HUT, and custom packaging. This is the right choice if the after-feel claim is central to your positioning rather than a supporting line.
| Symptom | Root cause | Prevention | Evidence to request |
|---|---|---|---|
| Sample approved, but consumers describe it as “heavy” on launch | Panel scored only at 22 °C / 50% RH | Add a stress-condition score to every round and report the delta | Paired scorecards for both environments |
| Visible white roll-off when sunscreen is applied over the cream | Layering never tested; incompatible thickener or film former | Mandate a layering test in the sampling protocol | Layering test report with sunscreen and makeup |
| Pump dispenses too much or clogs after two weeks | Emulsion viscosity drift versus the pump specification | Verify dose per actuation after stability, not only on day one | Actuation and dose data at 0 and 3 months, 40 °C |
| Odour or colour shift after storage in market | Fragrance oxidation or fragrance-plastic interaction | Run pack compatibility with the actual fragrance at the actual dose | Compatibility report with photo records at each checkpoint |
| Claim cannot be used after the study | Question wording, N, or timepoint changed mid-study, or the claim timepoint does not match the endpoint | Freeze the questionnaire and analysis plan before recruitment | Signed protocol, verbatim questionnaire, statistical report |
| Regulatory review flags the artwork | Label INCI does not match the manufacturing formula; missing allergen declarations | Reconcile artwork text against the controlled formula before print | Artwork-to-formula reconciliation sheet |
| Batch-to-batch sensory drift after launch | No Golden Sample, or the Golden was not updated after a change | Hold Approved, Golden, and Limit Samples with change-control rules | Signed sample register tied to formula, process, and pack version |
There is no universal number — it depends on the claim strength, the comparator, and the market. What matters is that the sample size is set in advance, matched to the target population, and stated in the report alongside the exact question and timepoint. Agree the N with your regulatory reviewer before recruitment rather than after results arrive.
No. Instrumental methods such as sebum measurement and image analysis support a performance claim, but they do not describe how the product feels. After-feel requires a consumer or trained-panel score. The strongest dossiers pair both, with the panel data and the instrumental data telling the same story.
Match the claim timepoint to what you actually tested. An 8-hour non-greasy claim needs an 8-hour measurement, not a 4-hour one extrapolated. If you want a longer-term effect such as “shine appears later,” plan a 2–4 week diary or instrumental arm in addition to the acute assessment.
Yes, because it controls dose. A jar and an airless pump deliver very different amounts per use, and the panel will notice. Test the after-feel at the dose the pack will realistically deliver, and confirm dose per actuation again after stability testing.
A claims substantiation file that maps each label statement to a specific test, question, or instrumental result. Without it, marketing copy and evidence drift apart, and the gap is usually discovered during regulatory review or at the first retailer audit.
If you are sourcing a non-greasy face cream for Gulf humidity and want the sample round to produce usable numbers rather than opinions, send us your target markets, pack direction, and claim intent. Request a Quote and we will return a sampling plan with the after-feel scorecard, test environments, and documentation list built in.
This article is informational only and does not constitute legal or regulatory advice. Confirm labelling, claims, and market entry requirements with a qualified regulatory professional for each destination market.